Senotherapy represents a cutting-edge approach within the field of biomedical science, targeting the elimination of senescent cells—cells that have ceased to divide and contribute to the aging process and age-related diseases. This innovative strategy aims to mitigate the detrimental effects of cellular senescence, such as tissue dysfunction and chronic inflammation, potentially leading to improved health outcomes and extended healthy lifespan. As a promising avenue of deep technology, senotherapy is exploring the development of senolytic agents, drugs designed to selectively clear these non-dividing cells, offering hope for combating various conditions associated with aging.